DOI: http://dx.doi.org/10.18203/2320-6012.ijrms20170175

Hepatic artery embolization for treating giant hemangioma of liver: an experience from a tertiary level hospital in India

Dharmik Bhuva, Manish Agrawal, Jawahar Rathod, Chandrakant Kamble, Anup Biswas

Abstract


Background: Transcatheter hepatic artery embolization (TAE) is a minimally invasive procedure. This study aimed to assess radiological features of giant haemangioma of liver on untrasonography, contrast enhanced tomography, magnetic resonance imaging and digital subtraction angiography, to assess the safety, feasibility and efficacy of transcatheter arterial embolization of hepatic artery in giant liver haemangioma.

Methods: This prospective study was conducted in the Interventional Radiology Department, Government Medical College Nagpur from September 2013 till August 2015. Patients were enrolled who were diagnosed with liver hemangioma after obtaining an informed consent. Patients underwent routine investigations and imaging modalities like ultrasonography, contrast enhanced computed tomography. Patients were followed up at 3 months and 9 months.

Results: During the study period, 28 patients were enrolled, 9 males, most common age group being 31-50 years. Abdominal discomfort was the most common symptom. Majority of the lesions were hyperechoic and not vascular. On CECT most of the lesions appeared progressive centripetal. On DSA heaptic artery was the most common source of vascular supple. Statistically significant change in size of the lesion was observed on either lobe when imaged via USG or CECT. No long term complications were seen in majority of the patients.

Conclusions: This study shows that TAE in Giant Hepatic Haemangiomas is safe, feasible, efficient, and minimally invasive with good patient acceptance, minimal complications and no mortality.

Keywords


Computer tomography, Embolization, Hemangioma, Treatment

Full Text:

PDF

References


Unal E, Francis F, Aquino A, Xu R, Morgan G, Teperman L. Liver transplant for mixed capillary-cavernous haemangioma masquerading as hepatocellular carcinoma in a patient with hepatocellular carcinoma. J Exp Clin Transplant. 2011;9(5):344-8.

Bioulac-Sage P, Laumonier H, Laurent C, Blanc JF, Balabaud C. Benign and malignant vascular tumors of the liver in adults. Seminar in Liver Disease. 2008;28:302-14.

Erdogan D, Busch OR, van Delden OM, Bennink RJ, ten Kate FJ, Gouma DJ, et al. Management of liver hemangiomas according to size and symptoms. J Gastroentero Hepato. 2007;22:1953-8.

Gandolfi L, Leo P, Solmi L, Vitelli E, Verros G, Colecchia A. Natural history of hepatic haemangiomas: clinical and ultrasound study. Gut. 1991;32:677-80.

Ng WW, Cheung YS, Lee KF, Wong J, Yu SC, Lee PS, et al. Is regular follow-up scan for giant liver haemangioma necessary? Hong Kong Med J. 2007;13(5):353.

Schwartz SI, Husser WC. Cavernous hemangioma of the liver. A single institution report of 16 resections. Annals of Surgery. 1987;205(5):456-65.

Ho HY, Wu TH, Yu MC, Lee WC, Chao TC, Chen MF. Surgical management of giant hepatic hemangiomas: complications and review of the literature. Chang Gung Med J. 2012;35(1):70-8.

Machado MM, Rosa ACF, Lemes MS, Mota OM, Silva OQ, et al. Liver haemangiomas: ultrasound and clinical features. Radiologia Brasileira. 2006;39(6):441-6.

Toro A, Mahfouz AE, Ardiri A, Malaguarnera M, Malaguarnera G, Loria F, et al. What is changing in indications and treatment of hepatic hemangiomas. A review. Magnetic resonance imaging. 2014;100:85-7.

Sun JH, Nie CH, Zhang YL, Zhou GH, Ai J, Zhou TY et al. Transcatheter Arterial Embolization Alone for Giant Hepatic Hemangioma. PloS ONE. 2015;10(8):e0135158.

Vilgrain V, Boulos L, Vullierme MP, Denys A, Terris B, Menu Y. Imaging of atypical hemangiomas of the liver with pathologic correlation. Radiographics. 2000;20(2):379-97.

Prasanna, Prasanth M, Scott E. Fredericks, Steven S. Winn, and Robert A. Christman. Giant Cavernous Hemangioma 1. Radiographics. 2010;30(4):1139-44.

Srivastava DN, Gandhi D, Seith A, Pande GK, Sahni P. Transcatheter arterial embolization in the treatment of symptomatic cavernous hemangiomas of the liver: a prospective study. Abdom Imaging. 2001;26(5):510-4.

Deutsch GS, Yeh KA, Bates WB, 3rd, Tannehill WB. Embolization for management of hepatic hemangiomas. Am Surg. 2001;67(2):159-64.

Mohan S, Gupta A, Verma A, Kathura MK, Baijal, SS. Case report: Non-surgical management of a giant liver hemangioma. Ind J Radi Ima. 2007;17(2):81.

Zeng Q, Li Y, Chen Y, Ouyang Y, He X, Zhang H. Gigantic cavernous haemangioma of the liver treated by intra-arterial embolization with pingyangmycin-lipiodol emulsion: a multi-center study. Cardiovasc Intervent Radiol. 2004;27:481-5.

Firouznia K, Ghanaati H, Alavian SM, Toosi MN, Daryani NE, Jalali AH, et al. Management of liver hemangioma using trans-catheter arterial embolization. Hepatitis monthly. 2014;14(12).

Panis Y, Fagniez P L, Cherqui D, Roche A, Schaal J C, Jaeck D. Successful arterial embolisation of giant liver haemangioma. HPB Surgery. 1993;7(2):141-6.